Merck is a big boy in their field of 11.6 Billion. Now we await...

Merck is a big boy in their field of 11.6 Billion. Now we await Roche in the ST future.

Investors will find this company hard to value until forcasts of product sales come in. It will fly when the company releases forcasts of 2011 and 12. As I expect the forcasted sales to come in at 10s of millions per year.

A 20c ST target is possible, being just over 100 mil MC for a punt on a company that could be worth over a billion in a year or 2. It a safe bet below this level- IMO.

This latest signing shows us that all the testing and research by the Big boys say this is a market changing biotech.

Good Luck to all holders...this will now get the attention of larger funds IMO. Once BANGS state they sold XYZ of the products then they making an income and will be revalued. Only a matter of time... IMO DYOR.